Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betaferon dosing in early SPMS
NCT00313976Phase 3Withdrawn
- Sponsor
- Bayer
- Modality
- Cytokines & Interferons
- Countries
- 2
01
Overview
A Phase 3 trial of interferon beta-1b in secondary-progressive multiple sclerosis (SPMS), sponsored by Bayer. Status: withdrawn.
02
Drugs
interferon beta-1b
03
Conditions
secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on NCT00313976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00313976.